Cervical Dystonia Market is Driven by Increasing Awareness and...

Cervical Dystonia Market is Driven by Increasing Awareness and Government Support

Posted 2025-02-28 10:45:19

Cervical dystonia, also known as spasmodic torticollis, is a neurological movement disorder characterized by involuntary muscle contractions and spasms in the neck muscles. Some of the symptoms include abnormal head positioning such as tilting, twisting and rotation of the neck. The condition causes the neck muscles to contract uncontrollably resulting in irregular or sustained neck postures. Treatment usually involves management with oral medications, Botulinum toxin injections or surgery. The global cervical dystonia market is gaining significant attention due to growing approvals of novel therapeutics and increasing awareness among patients.

The cervical dystonia market is estimated to be valued at USD 265.1 Mn in 2024 and is expected to reach USD 400.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031.

Key players operating in the cervical dystonia market are Merz Pharma GmbH & Co. KGaA, US WorldMeds, LLC., Ipsen Pharma, Allergan, Revance Therapeutics, Inc.

Key Takeaways

Key players operating in the cervical dystonia market are Merz Pharma GmbH & Co. KGaA, US WorldMeds, LLC., Ipsen Pharma, Allergan, Revance Therapeutics, Inc. Merz Pharma GmbH & Co. KGaA offers Xeomin for the treatment of cervical dystonia. US WorldMeds, LLC offers both generic and branded versions of botulinum toxin type A for the management of cervical dystonia.

The global Cervical Dystonia Market is primarily driven by the growing cases of cervical dystonia worldwide. According to the Dystonia Society, approximately 150,000 people in the U.S. have some form of focal dystonia including cervical dystonia. Increasing prevalence is attributed to rising environmental risk factors like head or neck injuries.

Geographically, North America dominates the global cervical dystonia treatment market owing to growing awareness levels among patients and rising healthcare investments. However, Asia Pacific region is expected to witness the highest growth over the forecast period due to increasing healthcare expenditure and growing cases of cervical dystonia attributed to lack of awareness.

Get more insights on – Cervical Dystonia Market

Get this Report in Japanese Language: 頸部ジストニア市場

Get this Report in Korean Language: 경부 디스토니아 시장